Essentiale forte N capsules 300mg, No. 90
Expiration Date: 11/2025
Russian Pharmacy name:
Эссенциале форте Н капсулы 300мг, №90
Chronic hepatitis, liver cirrhosis, fatty liver degeneration of various etiologies, toxic liver damage, pregnancy toxicosis, psoriasis (as a means of adjuvant therapy, radiation syndrome.
Inside. The capsules should be swallowed whole with plenty of water (about 1 glass).
For adolescents over 12 years old and weighing more than 43 kg, as well as for adults EssentialeЃ forte N, it is recommended to take 2 capsules - 3 times a day with meals.
As a rule, the duration of use is not limited.
1 capsule contains:
Active ingredient: phospholipids from soybeans containing 76% (3-sn-phosphatidyl) - choline (synonyms: EPL, essential phospholipids) - 300 mg;
Auxiliary ingredients: solid fat - 57,000 mg, soybean oil - 36,000 mg, hydrogenated castor oil - 1,600 mg, ethanol 96% - 8,100 mg, ethyl vanillin - 1,500 mg, 4-methoxyacetophenone - 0.800 mg, ?-tocopherol - 0.750 mg.
The composition of the capsule: gelatin - 67.945 mg, purified water - 11.495 mg, titanium dioxide (E 171) - 0.830 mg, iron dye yellow oxide (E 172) - 2.075 mg, iron dye black oxide (E 172) - 0.332 mg, iron dye red oxide (E 172) - 0.198 mg, sodium lauryl sulfate - 0.125 mg.
- Hypersensitivity to phosphatidylcholine, soybeans, soybeans or other ingredients of the drug.
- Children under 12 years of age (lack of sufficient evidence).
Trade name: EssentialeЃ forte N
Dosage form: capsules.
Composition:
1 capsule contains:
Active ingredient: phospholipids from soybeans containing 76% (3-sn-phosphatidyl) - choline (synonyms: EPL, essential phospholipids) - 300 mg;
Auxiliary ingredients: solid fat - 57,000 mg, soybean oil - 36,000 mg, hydrogenated castor oil - 1,600 mg, ethanol 96% - 8,100 mg, ethyl vanillin - 1,500 mg, 4-methoxyacetophenone - 0.800 mg, ?-tocopherol - 0.750 mg.
The composition of the capsule: gelatin - 67.945 mg, purified water - 11.495 mg, titanium dioxide (E 171) - 0.830 mg, iron dye yellow oxide (E 172) - 2.075 mg, iron dye black oxide (E 172) - 0.332 mg, iron dye red oxide (E 172) - 0.198 mg, sodium lauryl sulfate - 0.125 mg.
Description
Brown, opaque, oblong, hard gelatin capsules containing a yellowish brown, oily paste.
Pharmacotherapeutic group
Hepatoprotective agent.
Pharmacological properties
Essential phospholipids are the main elements in the structure of the cell membrane and cell organelles of the liver. They have a normalizing effect on the metabolism of lipids, proteins and on the detoxification function of the liver; restore and preserve the cellular structure of the liver and phospholipid-dependent enzymatic systems; inhibit the formation of connective tissue in the liver.
Indications for use
Chronic hepatitis, liver cirrhosis, fatty liver degeneration of various etiologies, toxic liver damage, pregnancy toxicosis, psoriasis (as a means of adjuvant therapy, radiation syndrome.
Contraindications
- Hypersensitivity to phosphatidylcholine, soy, soybeans or other ingredients of the drug.
- Children under 12 years of age (lack of sufficient evidence).
Application during pregnancy and during breastfeeding
Pregnancy
The use of EssentialeЃ forte N during pregnancy is not recommended without medical supervision. There is a lack of research.
Breastfeeding period
To date, no risks have been identified when using products containing soy during breastfeeding. However, due to the lack of relevant studies involving women during breastfeeding, the use of the drug
Method of administration and dosage
Inside. The capsules should be swallowed whole with plenty of water (about 1 glass).
For adolescents over 12 years old and weighing more than 43 kg, as well as for adults EssentialeЃ forte N, it is recommended to take 2 capsules - 3 times a day with meals.
As a rule, the duration of use is not limited.
Side effect
Essentiale forte N is usually well tolerated by patients, however, a feeling of discomfort in the abdomen and loosening of the stool can rarely be noted. Allergic reactions are possible.
Interaction with other drugs
So far not known.
Release form
Capsules 300 mg.
10, 12 or 15 capsules in a blister of PVC and aluminum foil, PVC / PTFE and aluminum foil or PVC / PE / PVDC and aluminum foil.
1) 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 18 blisters of 10 capsules together with instructions for use in a cardboard box.
2) 5 or 6 blisters of 10 capsules in a cardboard box. 3 carton packs with instructions for use in a carton box.
3) 3 blisters of 10 capsules in a cardboard box. 6 cardboard packs with instructions for use in a cardboard box.
4) 9 blisters of 10 capsules in a carton box. 2 cardboard boxes with instructions for use in a cardboard box.
5) 3, 4, 5, 6, 7, 8, 9, 10, 11 or 15 blisters of 12 capsules each with instructions for use in a cardboard box.
6) 2, 3, 4, 5, 6, 7, 8, 10 or 12 blisters of 15 capsules each with instructions for use in a cardboard box.
Shelf life is
3 years. Do not use after the expiration date.
Storage conditions
At a temperature not exceeding + 21 ? C, out of the reach of children.
Terms of dispensing from pharmacies
Without prescription.